Area 23.

The article focuses on Area 23's challenging but successful 2023 following a demanding launch year, achieving significant growth through new AOR engagements with major pharmaceutical companies like Regeneron, Pfizer, and others. Topics include the integration of McCann Health New York into Area 23, enhancing capabilities in strategy and creative output, leading to a notable business and creative turnaround prior to their formal merger.